New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
The faculty members appear on Thomson Reuters’ “Highly Cited Researchers 2014″ list.
A group of Northeastern students has joined the crusade to bring an end to the 17 neglected tropical diseases that affect more than 1 billion people around the world. Called NEU END7, the group has been working since October to raise awareness of NTDs and help eradicate the seven most common tropical infections by 2020.
Congratulations to chemistry Prof. John Engen, whose sabbatical research was recently featured in Cell!
Northeastern professor Barry Karger, whose contributions to analytical chemistry helped enable the sequencing of the human genome, received the Arnold O. Beckman Medal and Award for Outstanding Scientific Achievements in the field of electrodriven separation techniques.
The 2014 “Huntington 100″ honorees have been announced.
Penny Beuning’s research is based on relationships. Proteins, DNA, RNA in a dance of scientific compatibility. A dance that affects life, the fight against disease and understanding how to create new chemical reactions. An associate professor in Chemistry and Chemical Biology at Northeastern’s College of Science, Beuning’s groundbreaking efforts were documented recently in a paper published in “Structure.” In it, she detailed how various proteins might act in different situations in the lab.
Students and faculty across many disciplines presented their most recent scholarly research, innovative thinking, and entrepreneurial ventures on Thursday at RISE:2014, Northeastern’s Research, Innovation and Scholarship Expo.
Frustrating, enigmatic and enlightening. That’s how graduating senior Elise Miner describes her scientific research when striving to develop economically sustainable renewable energy sources.
Chemistry and chemical biology professor John R. Engen uses a novel technique to analyze large, complex biopharmaceutical drugs, which could have major implications for healthcare and its associated costs.